Abstract: Compounds of Formula (I): wherein R1, R3, R11, R12, X, Y1, Y2, Y3, Y4 and are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring anti-apoptotic inhibitors.

Abstract: In the method and the device described here for operating an electromagnetic, in particular magnetostrictive, or acoustic position measuring device (10) having at least one position sensor (44), at least one position encoder (20) and a waveguide (14), said position measuring device having a control device for triggering an interrogation pulse in the waveguide (14) and an evaluation unit for evaluating a wave form (400-450) recorded by the position sensor (44), wherein the time between the triggering of the interrogation pulse and the point in time at which the wave form (400-450) recorded by the position sensor (44) is recorded is measured to determine the position of the position encoder (20) via the relationship between distance and time, it is in particular provided that position recognition is implemented by means of the position encoder (20) by localising patterns in the wave form (400-450) recorded by the position sensor (44), wherein the localisation of such patterns is implemented on the basis of corr

Abstract: A sensor cleaning apparatus, for cleaning a sensor field of a sensor, in particular a LiDAR sensor, of a vehicle, includes at least one wiper drive housing, which houses at least a majority of at least one wiper drive unit. At least one wiper is arranged at least partially outside of the wiper drive housing and is configured to clean the sensor field by way of a wiping motion. At least one wiper receiving element is provided for transferring a drive movement from the wiper drive unit to the wiper. The sensor cleaning apparatus further includes a sealing unit configured for an at least water-tight seal of the wiper drive housing and includes at least one movable passage opening for the wiper receiving element and/or for the wiper.

Abstract: The present invention relates to the identification of the xcv-1 gene, which is responsible for a recessive resistance to Xanthomonas euvesicatoria, by genetic mapping-based cloning from Capsicum annuum. In addition, the invention relates to methods for generating plants resistant to an abiotic or biotic factor, in particular to Xanthomonas euvesicatoria, and the plants themselves, in particular tomato plants.

Abstract: Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R8, R14, W, A and n are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring a pro-apoptotic agent.

Abstract: Compounds of formula (I): wherein R1, R2, R5, R6, R7, R12, X, Y, A, E and n are as defined in the description. Medicinal products containing the same which are useful in treating a condition requiring a pro-apoptotic agent.

Abstract: Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R8, R14, W, A and n are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring a pro-apoptotic agent.

Abstract: Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R12, X, A and n are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

Abstract: Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R8, R14, W, A and n are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring a pro-apoptotic agent.

Abstract: Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R12, X, A and n are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

Abstract: Provided is a master printed circuit board (PCB). The master PCB includes panels defined by grooves cut in the master PCB, the grooves separating one panel from another. A final PCB is formable via use of one or more jumpers, wherein the jumpers are configured to extend across at least one of the grooves to electrically connect one panel to another panel. The electrically connected panels form the final PCB.

Abstract: Compounds of formula (I): wherein R1, R2, R5, R6, R7, R12, X, Y, A, E and n are as defined in the description. Medicinal products containing the same which are useful in treating a condition requiring a pro-apoptotic agent.

Abstract: The invention is a cooling system comprising adjacent cooling deltas (21, 31) being cooled by a cooling air and being arranged along a path (20, 30). The cooling system is characterized by comprising cooling deltas (21, 31) arranged in groups (22), the cooling deltas of a group (22) being arranged essentially in the same orientation and define an essentially straight path-section, wherein the path-sections of adjacent groups (22) form a zigzagged path (20, 30).

Abstract: Compounds of formula (I); wherein R1, R2, R3, R4, R5, R6, R7, R8, R14, W, A and n are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring a pro-apoptotic agent.

Abstract: The invention is a hybrid condenser having a direct contact condenser segment (9) and a surface condenser segment (10) arranged in a common condensation space. The hybrid condenser includes a surface condenser segment (10) arranged downstream the direct contact condenser segment (9) in the direction of steam flow or below the direct contact condenser segment (9), and a water guiding element (17) ensuring that the cooling water and condensate mixture generated in the direct contact condenser segment (9) flows downward avoiding the surface condenser segment (10).

Abstract: Provided is a master printed circuit board (PCB). The master PCB includes panels defined by grooves cut in the master PCB, the grooves separating one panel from another. A final PCB is formable via use of one or more jumpers, wherein the jumpers are configured to extend across at least one of the grooves to electrically connect one panel to another panel. The electrically connected panels form the final PCB.

Abstract: Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R12, X, A and n are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

Abstract: Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R12, X, A and n are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

Abstract: The present invention relates to the identification of the xcv-1 gene, which is responsible for a recessive resistance to Xanthomonas euvesicatoria, by genetic mapping-based cloning from Capsicum annuum. In addition, the invention relates to methods for generating plants resistant to an abiotic or biotic factor, in particular to Xanthomonas euvesicatoria, and the plants themselves, in particular tomato plants.